He Li

机构：Anyang Eye Hospital · ORCID：0000-0002-1766-5311

发表论文 95 篇 · 总被引 1670 次 · h-index 21

代表论文

• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma (2024 · New England Journal of Medicine · 被引 167)
• COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma (2024 · Biochimica et Biophysica Acta (BBA) - General Subjects · 被引 38)
• Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma (2024 · JAMA Network Open · 被引 15)
• Identification of USP9X as a leukemia susceptibility gene (2023 · Blood Advances · 被引 14)
• Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 12)
• HMZDupFinder: a robust computational approach for detecting intragenic homozygous duplications from exome sequencing data (2023 · Nucleic Acids Research · 被引 10)